PE-22-28
Half-life
30 min
Time to Peak
9 min
Steady State
~1 days
Dose Range
200–1000 mcg
Frequency
Daily
Overview
Synthetic peptide fragment derived from the protein phosphatase 1 regulatory subunit. Used in the nootropic community for memory enhancement and neuroplasticity. Very experimental with minimal published human data. Primarily administered intranasally.
Mechanism of Action
Modulates protein phosphatase 1 (PP1) activity to enhance long-term potentiation (LTP) and memory consolidation. Targets molecular memory erasure mechanisms.
Dosing Information
| Route | Dose Range | Half-life | Tmax | Frequency |
|---|---|---|---|---|
| Nasal | 200–1000 mcg | 30 min | 9 min | Daily |
Storage & Handling
2-8C — Store refrigerated. Primarily used intranasally. Highly experimental — very limited human data.
Used in Regimens
PE-22-28 is not currently part of any catalog regimen.
Data Sources
- animal data PE-22-28 PP1 inhibition and memory enhancement
Related Tools
Track PE-22-28 with Doseline
Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.